CAH StripAssay®
Congenital Adrenal Hyperplasia Confirmation
The CAH StripAssay® is a cost-effective tool for the genetic confirmation of Congenital Adrenal Hyperplasia (CAH) early in the disease cycle, helping minimize emotional stress for families and reducing false positives from neonatal 17-OHP screening.
Key Features
Confirmatory Genetic Testing
Provides reliable genetic confirmation of Congenital Adrenal Hyperplasia (CAH) early in the disease cycle.
Reduces False Positives
Addresses the high false-positive rate of neonatal 17-OHP screening, enabling accurate early diagnosis.
Early Intervention Support
Early and reliable CAH diagnosis minimizes emotional stress for families and reduces the economic burden of misdiagnosis.
PCR & Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for consistent, reproducible results.
For Research Use Only (RUO)
CAH StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.